Hypermonones A—I, New Polyprenylated Acylphloroglucinols from Hypericum monogynum with Multidrug Resistance Reversal Activity

Yan‐Rong Zeng,Ya‐Nan Li,Jue Yang,Ping Yi,Lei Huang,Lie‐Jun Huang,Wei Gu,Zhan‐Xing Hu,Yan‐Mei Li,Chun‐Mao Yuan,Xiao‐Jiang Hao
DOI: https://doi.org/10.1002/cjoc.202100210
IF: 5.56
2021-07-23
Chinese Journal of Chemistry
Abstract:<p>Eleven biogenetically related polyprenylated acylphloroglucinols (PPAPs), including four novel skeletons (<b>1</b>–<b>4</b>) and five new compounds (<b>5</b>–<b>9</b>), were isolated from the flowers of Hypericum monogynum. Hypermonones A–D (<b>1</b>–<b>4</b>) represented the first</p><p>examples of a unique dilactone structure containing carbonyl bonded single δ‐lactone and tricyclic γ‐lactone moieties. Their structures were elucidated by NMR analysis, X‐ray crystallography, and ECD calculations. Moreover, we revised the structure of hyperibrin B to hypermonone I (<b>9</b>) via NMR analysis, a quantum computational chemistry method, and hypothetic biosynthetic considerations. Three compounds (<b>5</b>, <b>6</b>, and <b>9</b>) with significant MDR reversal activity (RF ranging from 61 to 223) were superior to the positive control verapamil (MCF‐7/ADR, RF: 53; HepG2/ADR, RF: 124). Mechanism study for compound <b>5</b>, a high affinitive substrate of P‐gp, could inhibit the function of P‐gp transport rather than its expression, and the possible recognition mechanism between compound <b>5</b> and P‐gp was predicted by molecular docking.</p><p>This article is protected by copyright. All rights reserved.</p>
chemistry, multidisciplinary
What problem does this paper attempt to address?